Prolonged percutaneous SNM testing does not cause infection-related explanation
BJU International, 06/29/2012
Amend B et al. – There are few studies in the literature evaluating sacral neuromodulation (SNM) testing periods vs the risk of clinically relevant implant infection rates. The present study shows that prolonged testing could potentially enhance treatment efficacy without infection–related explantations of the chronic implant, despite the identification of bacteria. SNM–implanted patients with diabetes mellitus or obesity should be followed closely. Clinicians might consider using prolonged testing under everyday conditions. Prolonged SNM stage 1 testing is a very effective minimally invasive treatment option to evaluate pelvic–related dysfunction.